Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†. (Q44685863)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

clinical oncology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hiroko Tsukada

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Akira Yokoyama

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Koichi Goto

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Tetsu Shinkai

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Masao Harada

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Masahiko Ando

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Taro Shibata

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yuichiro Ohe

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Tomohide Tamura

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Nagahiro Saijo

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Lung Cancer Study Group of the Japan Clinical Oncology Group (JCOG)

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

6 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

88-95

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Non-small cell lung cancer in the elderly: defining treatment options

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Evaluating the older patient with cancer: understanding frailty and the geriatric assessment

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Discrete sequential boundaries for clinical trials

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Phase I trial of weekly docetaxel in elderly patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.

1 reference

https://api.crossref.org/works/10.1093/JJCO/HYU176

21 January 2018

Identifiers

10.1093/JJCO/HYU176

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

release_xy5tmypgajchtkq3ghw73rtuwu

1 reference

https://api.fatcat.wiki/v0/release/xy5tmypgajchtkq3ghw73rtuwu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44685863&oldid=1843810212"